doi: 10.1210/en.2007-1292 Summary Keywords GLP-1, DPP-4, fracture, diabetes, bone, osteoporosis, antidiabetic, glucose-lowering drugs Citation Al-Mashhadi ZK, Viggers R, Fuglsang-Nielsen R, Vestergaard P, Gregersen S and Starup-Linde J (2022) The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
Common approaches include: Prior authorization requirements BMI and clinical eligibility criteria Step therapy protocols Lifestyle coaching programs Clinical support and case management Condition-specific coverage guidelines Notably, 34% of employers now require participation in a lifestyle or clinical support program before approving GLP-1 therapyup significantly from prior years
JAMA 308 , 11501159 (2012)
This study shows that EGT plays a more important role than MSH in S